Skip to main content

Table 8 Risk factors of NAFLD in overweight and non-overweight women with PCOS

From: Hepatic steatosis in women with polycystic ovary syndrome

 

Non-overweight group N(%)

Overweight group N(%)

P

Central obesity

16 (16.0%)

93 (90.3%)

< 0.001

Increased blood pressure

3 (8.8%)

24 (50.0%)

< 0.001

Hypertriglyceridemia

13 (12.5%)

27 (26.2%)

0.012

Hyperlipidemia

36 (34.6%)

50 (48.5%)

0.042

Abnormal blood glucose

18 (17.1%)

36 (35.6%)

0.003

HOMA-IR ≥ 3.54

10 (9.9%)

59 (50.0%)

< 0.001

Metabolic syndrome

1 (0.9%)

35 (34%)

< 0.001

Abnormal liver enzymes

8 (7.5%)

20 (19.4%)

0.012

ALT ≥ 18.2

32 (30.2%)

61 (59.2%)

< 0.001

FAI > 8

25 (26.6%)

50 (57.5%)

< 0.001

Hirsutism

34 (32.4%)

33 (32.7%)

0.964

Acne

50 (47.6%)

45 (44.1%)

0.613

PCOM

84 (88.4%)

82 (92.1%)

0.397

  1. The ‘N (%)’ in each cell represented ‘the number of patients with this risk factor in this age group (the percentage of patients with this risk factor in this age group). Patients were excluded if the factor to be analyzed was missing